[1] Kang Q, Yang C.Oxidative stress and diabetic retinopathy: molecular mechanisms, pathogenetic role and therapeutic implications[J]. Redox Biology, 2020, 37: 101799.
[2] Mahajan N, Arora P, Sandhir R.Perturbed biochemical pathways and associated oxidative stress lead to vascular dysfunctions in diabetic retinopathy[J]. Oxidative Medicine and Cellular Longevity, 2019, 2019: 8458472.
[3] Cvitkovic K, Sesar A, Sesar I, et al.Concentrations of selected cytokines and vascular endothelial growth factor in aqueous humor and serum of diabetic patients[J]. Seminars in Ophthalmology, 2020, 35(2): 126-133.
[4] Liu R, Liu C, Cui L, et al.Expression and significance of MiR-126 and VEGF in proliferative diabetic retinopathy[J]. European Review for Medical and Pharmacological Sciences, 2019, 23(15): 6387-6393.
[5] 张政伟,张岩,陈拥军,等. 糖尿病视网膜病变患者糖化血红蛋白及血管内皮生长因子的表达及临床意义[J]. 四川解剖学杂志,2020,28(2):145, 147.
[6] 金梅,李晓凤. 糖尿病视网膜病变患者血清中细胞因子及视网膜中央动脉血流动力学的变化[J]. 眼科新进展,2019,39(5):453-455,460.
[7] Bozkurt E, Çakır B, Çelik E, et al.Correlation of the aqueous humor total antioxidant capacity, total oxidant status, and levels of IL-6 and VEGF with diabetic retinopathy status[J]. Arq Bras Oftalmol, 2019, 82(2): 136-140.
[8] Niranjan G, Srinivas AR, Srikanth K, et al.Evaluation of circulating plasma VEGF-A, ET-1 and Magnesium levels as the predictive markers for proliferative diabetic retinopathy[J]. Indian Journal of Clinical Biochemistry, 2019, 34(3): 352-356.
[9] Xi G, Wai C, Clemmons D.Inhibition of Aberrant IGF-I Signaling in Diabetic Male Rat Retina Prevents and Reverses Changes of Diabetic Retinopathy[J]. Journal of Diabetes Research, 2019, 2019: 6456032.
[10] 陈娟,高鹏霞. 血清中胰岛素样生长因子Ⅰ、肿瘤坏死因子α、血管内皮生长因子165在糖尿病视网膜病变中的诊断价值[J]. 中华内分泌代谢杂志,2018,34(11):935-938.
[11] Zhang S, Wang J, Song C, et al.Lower prevalence of proliferative diabetic retinopathy in elderly onset patients with diabetes[J]. Diabetes Research and Clinical Practice, 2017, 125: 47-52.
[12] Kaul K, Hodgkinson A, Tarr JM, et al.Is inflammation a common retinal-renal-nerve pathogenic link in diabetes?[J]. Current Diabetes Reviews, 2010, 6(5): 294-303.
[13] 陈庆中,江枫,毛春洁,等. 血管内皮生长抑制因子在糖尿病视网膜病变大鼠中的表达[J]. 中华眼底病杂志,2014,30(2):180-186.
[14] Stahel M, Becker M, Graf N, et al.Systemic interleukin 1β inhibition in proliferative diabetic retinopathy: a prospective open-label study using canakinumab[J]. Retina, 2016, 36(2): 385-391.
[15] Li S, Yang H, Chen X.Protective effects of sulforaphane on diabetic retinopathy: activation of the Nrf2 pathway and inhibition of NLRP3 inflammasome formation[J]. Experimental Animals, 2019, 68(2): 221-231.
[16] 司长峰,卜荔,徐楠,等. 柴胡皂苷D对糖尿病视网膜病变大鼠的治疗作用[J]. 眼科新进展, 2021,41(10): 925-929.
[17] Semeraro F, Morescalchi F, Cancarini A, et al.Diabetic retinopathy, a vascular and inflammatory disease: Therapeutic implications[J]. Diabetes & Metabolism, 2019, 45(6): 517-527.
[18] Yao Y, Du J, Li R, et al.Association between ICAM-1 level and diabetic retinopathy: a review and meta-analysis[J]. Postgraduate Medical Journal, 2019, 95(1121): 162-168.
[19] Loporchio DF, Tam EK, CHO J, et al.Cytokine levels in human vitreous in proliferative diabetic retinopathy[J]. Cells, 2021, 10(5): 1069.
[20] Abu El-asrar AM, Ahmad A, Siddiquei MM, et al. The proinflammatory and proangiogenic macrophage migration inhibitory factor is a potential regulator in proliferative diabetic retinopathy[J]. Frontiers in Immunology, 2019,10: 2752.
[21] 王康,王艳玲,高立新,等. 地塞米松对糖尿病大鼠视网膜血管内白细胞聚集、血管通透性及细胞间黏附因子-1表达的影响[J]. 中华眼底病杂志,2007,23(4):273-276.
[22] Song S, Yu X, Zhang P, et al.Increased levels of cytokines in the aqueous humor correlate with the severity of diabetic retinopathy[J]. J Diabetes Complications, 2020, 34(9): 107641.
[23] Taghavi Y, Hassanshahi G, Kounis NG, et al.Monocyte chemoattractant protein-1 (MCP-1/CCL2) in diabetic retinopathy: latest evidence and clinical considerations[J]. J Cell Commun Signal, 2019, 13(4): 451-462.
[24] Chen N, Jiang K, Yan G.Effect of fenofibrate on diabetic retinopathy in rats via SIRT1/NF-κB signaling pathway[J]. European Review for Medical and Pharmacological Sciences, 2019, 23(19): 8630-8636.
[25] 杨帆,董志军,董微丽,等. 丝胶对2型糖尿病大鼠视网膜NF-κB表达的影响[J]. 承德医学院学报,2017,34(3):181-183.
[26] 付琳,袁霞,钱波. 超敏C反应蛋白在不同分期糖尿病视网膜病变患者中的变化及意义[J]. 检验医学与临床,2019,16(19):2881-2883.
[27] Song J, Chen S, Liu X, et al.Relationship between c-reactive protein level and diabetic retinopathy: A systematic review and meta-analysis[J]. PLoS One, 2015, 10(12): e144406.
[28] Bai S, Wang W, Ye L, et al.IL-17 stimulates neutrophils to release S100A8/A9 to promote lung epithelial cell apoptosis in mycoplasma pneumoniae-induced pneumonia in children[J]. Biomed Pharmacother, 2021,143: 112184.
[29] 于荣国,张慧,张晓敏,等. 糖尿病视网膜病变患者循环外泌体中炎症相关蛋白S100A8的表达[J]. 中华眼底病杂志,2021,37(1):32-39.
[30] Lim RR, Vaidya T, Gadde SG, et al.Correlation between systemic S100A8 and S100A9 levels and severity of diabetic retinopathy in patients with type 2 diabetes mellitus[J]. Diabetes & Metabolic Syndrome, 2019, 13(2): 1581-1589.
[31] Jin J, Zhang J, Bu S.Tasquinimod efficacy and S100A9 expression in glucose-treated HREC cells[J]. International Ophthalmology, 2022, 42(2): 661-676.
[32] Pan S, Hu Y, Hu M, et al.S100A8 facilitates cholangiocarcinoma metastasis via upregulation of VEGF through TLR4/NF-κB pathway activation[J]. International Journal of Oncology, 2020, 56(1): 101-112. |
